Clinical Trial Update: Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery [NA]

View source ↗

Summary

Clinical trial evaluating Doxorubicin Hydrochloride Liposome for treating ductal carcinoma in situ in women undergoing surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• DOXORUBICIN HYDROCHLORIDE LIPOSOME (DOXORUBICIN HYDROCHLORIDE)

Snippet

Sponsor: Dr. Susan Love Research Foundation | Conditions: Breast Cancer | NA | Status: UNKNOWN